₹975.10 15.10 (1.57%)
04:01 PM, 18-Feb-2025₹985.55 25.55 (2.66%)
03:53 PM, 18-Feb-2025BSE : 544210
NSE : EMCURE
Sector : Health care
ISIN Code : INE168P01015
Last Updated: 18-Feb-2025 | 04:01 PM IST
Market Cap (₹ Cr) | 18,471 |
Traded Value (₹ Cr) | 0.95 |
Volume (Shares) | 9,697 |
Face Value (₹) | 10 |
52-Week High (₹) | 1,577.50 |
52-Week High Date | 18-Sep-2024 |
52-Week Low (₹) | 942.45 |
52-Week Low Date | 18-Feb-2025 |
All Time High (₹) | 1,577.50 |
All Time High Date | 18-Sep-2024 |
All Time Low (₹) | 942.45 |
All Time Low Date | 18-Feb-2025 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 18,669 |
EPS - TTM (₹) [C] | 32.08 |
P/E Ratio (X) [C] | 30.72 |
Face Value (₹) | 10 |
Latest Dividend (%) | - |
Latest Dividend Date | - |
Dividend Yield (%) | 0.19 |
Book Value Share (₹) [C] | 217.42 |
P/B Ratio (₹) [C] | 4.53 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Nippon India Multi Cap Fund (G) | 122.85 | 10,00,000 | 0.33 |
Nippon India Multi Cap Fund (IDCW) | 122.85 | 10,00,000 | 0.33 |
Nippon India Multi Cap Fund (B) | 122.85 | 10,00,000 | 0.33 |
Nippon India Multi Cap Fund - Direct (G) | 122.85 | 10,00,000 | 0.33 |
Nippon India Multi Cap Fund - Direct (B) | 122.85 | 10,00,000 | 0.33 |
Nippon India Multi Cap Fund - Direct (IDCW) | 122.85 | 10,00,000 | 0.33 |
Aditya Birla SL ELSS Tax Saver Fund (IDCW) | 51.37 | 4,18,179 | 0.35 |
Aditya Birla SL ELSS Tax Saver Fund (G) | 51.37 | 4,18,179 | 0.35 |
Aditya Birla SL ELSS Tax Saver Fund - Direct (IDCW) | 51.37 | 4,18,179 | 0.35 |
Aditya Birla SL ELSS Tax Saver Fund - Direct (G) | 51.37 | 4,18,179 | 0.35 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 941.50 1,018.00 |
Week Low/High (₹) | 941.50 1,180.00 |
Month Low/High (₹) | 941.50 1,399.00 |
Year Low/High (₹) | 941.50 1,580.00 |
All time Low/High (₹) | 941.50 1,580.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -10.58% | -11.28% | -0.43% | -0.55% |
1 Month | -27.60% | -27.64% | -0.85% | -1.11% |
3 Month | -24.80% | -24.49% | -1.77% | -2.17% |
6 Month | -21.70% | -21.70% | -5.56% | -6.50% |
1 Year | - | - | 4.89% | 4.10% |
3 Year | - | - | 31.36% | 32.81% |
Whole Time Director : MUKUND KESHAO GURJAR
Whole Time Director : SUNIL RAJNIKANT MEHTA
Managing Director & CEO : SATISH RAMANLAL MEHTA
Chairman & Independent Directo : Berjis M Desai
Whole Time Director : NAMITA VIKAS THAPAR
Independent Director : P S Jayakumar
Independent Director : Vijay Gokhale
Independent Director : Vidya Rajiv Yeravdekar
Non Executive Director : Samonnoi Banerjee
Independent Director : Shailesh Ayyangar
Whole-time Director : SAMIT SATISH MEHTA
Company Sec. & Compli. Officer : CHETAN RAJENDRA SHARMA
Registered Office: Plot # P-1 & P-2 IT BT Park, Phase II MIDC Hinjawadi,Pune,Maharashtra-411057 Ph: +91 20 3507 0033/+91 20 3507 0000
Email:investors@emcure.com
1. What's the Emcure Pharmaceuticals Ltd share price today?
Emcure Pharmaceuticals Ltd share price was Rs 975.10 at 04:01 PM IST on 18th Feb 2025. Emcure Pharmaceuticals Ltd share price was up by 1.57% over the previous closing price of Rs 960.00. Emcure Pharmaceuticals Ltd share price trend:
2. How can I quickly analyse the performance of the Emcure Pharmaceuticals Ltd stock?
The performance of the Emcure Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Emcure Pharmaceuticals Ltd?
Emcure Pharmaceuticals Ltd has a market capitalisation of Rs 18,471 crore.
4. What is Emcure Pharmaceuticals Ltd's 52-week high/low share price?
The Emcure Pharmaceuticals Ltd’s 52-week high share price is Rs 1,577.50 and 52-week low share price is Rs 942.45.
5. Is the Emcure Pharmaceuticals Ltd profitable?
On a consolidated basis, Emcure Pharmaceuticals Ltd reported a profit of Rs 50.20 crore on a total income of Rs 1,055.33 crore for the quarter ended 2024. For the year ended Dec 2024, Emcure Pharmaceuticals Ltd had posted a profit of Rs 156.09 crore on a total income of Rs 1,959.39 crore.
6. Which are Emcure Pharmaceuticals Ltd’s peers in the Health care sector?
Emcure Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Gland Pharma, Wockhardt, Pfizer, Emcure Pharma, Concord Biotech, Astrazeneca Phar, ERIS Lifescience.
7. Who owns how much in Emcure Pharmaceuticals Ltd?
Key changes to the Emcure Pharmaceuticals Ltd shareholding are as follows: